These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25129065)

  • 21. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
    Wang SR; Huang KC; Lin TT; Chuang SL; Yang YY; Wu CK; Lin LY
    Int J Cardiol; 2024 Aug; 409():132198. PubMed ID: 38782070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
    Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
    J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
    Guerra F; Hohnloser SH; Kowey PR; Crijns HJ; Aliot EM; Radzik D; Roy D; Connolly S; Capucci A
    Clin Cardiol; 2014 Dec; 37(12):717-24. PubMed ID: 25470298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.
    Andersen SS; Hansen ML; Gislason GH; Schramm TK; Folke F; Fosbøl E; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C
    Europace; 2009 Jul; 11(7):886-91. PubMed ID: 19443433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
    Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
    Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study.
    Kochiadakis GE; Igoumenidis NE; Marketou ME; Kaleboubas MD; Simantirakis EN; Vardas PE
    Heart; 2000 Sep; 84(3):251-7. PubMed ID: 10956284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.
    Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):292-300. PubMed ID: 25829248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between use of amiodarone for non-valvular atrial fibrillation and patient survival: from the prospective China Atrial Fibrillation Registry.
    Hou XX; He L; Du X; Wang GH; Dong JZ; Ma CS
    Chin Med J (Engl); 2020 Dec; 134(3):309-317. PubMed ID: 33273373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality risk of sotalol and amiodarone for post-CABG atrial fibrillation.
    Johnson SM; Brophy JM
    Int J Cardiol; 2016 Jul; 214():502-7. PubMed ID: 27107151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease.
    Kovoor P; Eipper V; Byth K; Cooper MJ; Uther JB; Ross DL
    Eur Heart J; 1999 Mar; 20(5):364-74. PubMed ID: 10206383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
    Biffi M; Boriani G; Bartolotti M; Bacchi Reggiani L; Zannoli R; Branzi A
    Heart; 2002 May; 87(5):443-8. PubMed ID: 11997417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
    Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is either sotalol or amiodarone more effective than digoxin for converting patients with new-onset atrial fibrillation (AF) to sinus rhythm within 48 hours?
    Forney AJ; Schooff M
    J Fam Pract; 2000 Nov; 49(11):982. PubMed ID: 11093561
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current status of the clinical practice and analysis on the ratioanl prescription of antiarrhythmic drugs in Chinese patients with atrial fibrillation: Results from the Chinese Atrial Fibrillation Registry (CAFR) trial].
    Sun LJ; Du X; Liu SW; He R; Zeng H; Sun C; Li L; Zhang Y; Ma CS; Gao W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):740-747. PubMed ID: 32957756
    [No Abstract]   [Full Text] [Related]  

  • 37. The frequency analysis of signal-averaged ECG of P wave as predictor of efficacy of class III antiarrhythmic drugs to maintain sinus rhythm in recurrent idiopathic atrial fibrillation.
    Barbosa EC; Barbosa PR; Ginefra P; de Souza Bomfim A; Boghossian SH; da Rocha PJ; Filho FM
    Ann Noninvasive Electrocardiol; 2001 Jan; 6(1):43-9. PubMed ID: 11174862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular hypertrophy and antiarrhythmic drugs in atrial fibrillation: impact on mortality.
    Chung R; Houghtaling PL; Tchou M; Niebauer MJ; Lindsay BD; Tchou PJ; Chung MK
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1338-48. PubMed ID: 24831860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.